Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid (Q34658779)

3 August 2017

Single- and multiple-dose pharmacokinetics and absolute bioavailability of tedizolid (English)

1 reference

3 August 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

Shawn Flanagan

1

1 reference

3 August 2017

Edward Fang

2

1 reference

3 August 2017

Kelly A Muñoz

3

1 reference

3 August 2017

Sonia L Minassian

4

1 reference

3 August 2017

Philippe G Prokocimer

5

1 reference

3 August 2017

language of work or name

English

0 references

publication date

3 July 2014

1 reference

3 August 2017

1 reference

3 August 2017

34

1 reference

3 August 2017

9

1 reference

3 August 2017

891-900

1 reference

Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Pharmacokinetics of tedizolid following oral administration: single and multiple dose, effect of food, and comparison of two solid forms of the prodrug

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Potential role of tedizolid phosphate in the treatment of acute bacterial skin infections

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Prodrugs--from serendipity to rational design.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Phase 2, randomized, double-blind, dose-ranging study evaluating the safety, tolerability, population pharmacokinetics, and efficacy of oral torezolid phosphate in patients with complicated skin and skin structure infections.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Complicated skin and soft tissue infection

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Staphylococcus aureus-associated skin and soft tissue infections in ambulatory care

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Management of community-acquired pneumonia: a focus on conversion from hospital to the ambulatory setting

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4260119

Absorption rate limit considerations for oral phosphate prodrugs

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FPHAR.1458

Infection control--a battle in vein: infusion phlebitis

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24989138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early switch to oral treatment in patients with moderate to severe community-acquired pneumonia: a meta-analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24989138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Implementing a pharmacist-led sequential antimicrobial therapy strategy: a controlled before-and-after study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24989138

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/PHAR.1458

1 reference

3 August 2017

1 reference

3 August 2017

1 reference